Benjamin L. Palleiko, CEO: KalVista Pharmaceuticals KALV Sell · Filed 25/05/23

Trade details

Type: Insider sale
Amount: $118,788.12
Shares · price: 9,999 sh · $11.88 a share
Held after: 306,618 sh
Stock: KalVista Pharmaceuticals KALV
Person: Benjamin L. PalleikoCEO
Trade date: 25/05/22
Filed: 25/05/23
Days to filing: 1 days

Sold 3.2% of holdings

Share of holding sold: 3.2%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/04/22~25/06/21

Benjamin L. Palleiko's recent trades

Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$292.6K
10,926 sh
$292.6K
Filed 05/26
Traded 05/22
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$30.2K
1,129 sh
$30.2K
Filed 05/19
Traded 05/18
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$88.7K
3,322 sh
$88.7K
Filed 05/13
Traded 05/12
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$193.1K
9,550 sh
$193.1K
Filed 04/20
Traded 04/17
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$107.6K
6,693 sh
$107.6K
Filed 03/10
Traded 03/09